We use cookies essential for this site to function well. Please click "Accept" to help us improve its usefulness with additional cookies. Learn about our use of cookies, and collaboration with select social media and trusted analytics partners here.

Accept Use minimal essential cookies

Insights on Pharmaceuticals & Medical Products

Article

A new prescription for M&A in pharma

– Adopting a through-cycle approach to deal making in the wake of the COVID-19 pandemic can position pharmaceutical companies for greater success in the next normal.
Article

An optimistic scenario for the US response to COVID-19
– Much would need to happen, but returning the country to something that approaches stability by next summer may be possible.
Article

The European path to reimbursement for digital health solutions
– The “fail fast and break things” approach that tech start-ups favor probably won’t work in healthcare. A slower,... more deliberate route to market and reimbursement is required.
Survey

The need for speed in the post-COVID-19 era—and how to achieve it
– Survey findings confirm that organizational speed is an essential ingredient for outperformance in times of unprecedented change,... and point to three ways companies can gain speed for the longer term.
Article

Delivering innovation: 2020 oncology market outlook
– At the dawn of a new decade, we take stock of advances and unmet needs in the oncology pharmaceutical market. What will it take... to deliver innovation to patients over the next ten years?
Article

Managing China’s growing oncology burden
– Significant increases in incidence rates have made cancer a high priority in China. Progress has resulted from innovative treatments... and greater access to care, yet much more needs to be done.
Interview

GSK’s Brian McNamara on the business impact of COVID-19
– The CEO of GlaxoSmithKline Consumer Healthcare discusses the global challenges and possibilities of the next normal and the shifts... now underway in consumer behavior.
Article

Medtech’s call to action: Meeting the demand surge caused by COVID-19
– Five interventions have helped manufacturers ease supply constraints for medtech products during the pandemic. Important lessons... have been learned along the way.
Article

Ten battlegrounds for digital and analytics in life sciences
– Life-sciences companies have yet to realize the full potential of digital and analytics. Pioneers are finding success by focusing... on entire parts of the business system rather than use case projects.

Special collections

Collection

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how we treat and potentially cure certain diseases. This collection of articles provides an in-depth look at the opportunities and challenges ahead and the implications for stakeholders in this fast-evolving field. Contact us to learn more.

Collection

The Rise of Health Technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Learn more

More insights

Executive Briefing

COVID-19: Implications for business
– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.
Article

Improving the fragile US supply of blood
– For a system that relies on the altruism of contributors, an aging class of donors and changing attitudes put the nation’s... blood supply at risk.
Article

COVID-19 exposes a critical shortage of oxygen in developing countries
– The COVID-19 crisis is exacerbating what is considered a critical vulnerability in the health infrastructure of many developing... countries—a severe shortage of medical oxygen.
Article

COVID-19 and cell and gene therapy: How to keep innovation on track
– Cell and gene therapies promise life-changing treatments, but the pandemic has hit the sector hard. A survey reveals the extent... of the disruption and suggests actions to help companies become more resilient.
Article

Automation and the future of work in the US biopharma industry
– The US biopharma industry has been slower than some others to embrace enterprise-wide automation. As it accelerates adoption,... it will radically alter the future of work for its employees.
Interview - McKinsey Quarterly

Safeguarding the lifeblood of American healthcare: An interview with the CEO of AmerisourceBergen
– Steve Collis reflects on the resilience of medical supply chains, remote leadership during a crisis, and the importance of purpose... as a unifying force.
Interview

How Zoetis’s new CEO reset priorities and empowered employees during the pandemic
– Kristin Peck explains how letting local managers make their own decisions has helped the animal-health company to weather the... COVID-19 crisis successfully.
Article

On pins and needles: Will COVID-19 vaccines ‘save the world’?
– Innovators are sprinting to develop inoculations against the novel coronavirus. Here, we summarize the latest information on research... timelines and the potential impact of a vaccine on the pandemic—and society.
Podcast - McKinsey Global Institute

AI in healthcare: Microsoft’s Kevin Scott on how tech can treat a pandemic
– Machine learning to develop vaccines faster; wearable devices to detect illness sooner: the COVID-19 pandemic could spark significant... innovations in healthcare technologies.
Article

Creating value from next-generation real-world evidence
– Leading pharma companies are applying advanced analytics to real-world evidence generation to deliver impact at scale. How can... leaders keep innovating, and what should others do to catch up?
Article

Why tech transfer may be critical to beating COVID-19
– How quickly COVID-19 vaccine production ramps up will depend on technology transfer—the capabilities and processes that... can speed vaccines from development to manufacturing. Are we ready?
Sorry, we couldn't find any results. Try removing some filters.
View more

More from this practice

McKinsey Cancer Center

The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.

Related practice

Connect with our Pharmaceuticals & Medical Products Practice

Contact